Forecasts Significant Growth in Erectile Dysfunction Market, Expects CAGR of 6.2% and surpasses US$ 10.14 billion by 2030
Posted July 19, 2023 by nikita07072002
Erectile Dysfunction Market, By Therapy Type (Drug Therapy and Device Therapy), and By Region (North America, Asia Pacific, Europe, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030
Feature News
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/141
Key Highlights:
In 2019, Boston Scientific (NYSE:BSX) recently launched what it describes as a durable, natural-feeling implant to treat erectile dysfunction.
In 2021, -Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced positive topline results from a Phase 3 study evaluating the safety and efficacy of ULTOMIRIS (ravulizumab-cwvz) in adults with generalized myasthenia gravis (gMG).
--- END ---
| Contact Email | [email protected] |
| Issued By | nikita gawade |
| Phone | 91 7775049802 |
| Business Address | BadilloStreet |
| Country | United States |
| Categories | Health |
| Tags | erectile dysfunction market trends |
| Last Updated | July 19, 2023 |